dry mouth from tirzepatide GLP-1 Medications and Mouth: Managing New Side Effects 7 Surprising Ways Eli Lilly's

Saxenda also has more than a decade of post-market safety data, which matters to some patients and clinicians

Between January 2019 and June 2026, 383 cases of acute and chronic pancreatitis associated with semaglutide use were reported to the MHRA, 5 of which had a fatal outcome 12

New evidence suggests that research and clinical practices should move away from relying on symptoms and experiences as a diagnostic and results-based tool

A New Indication for Semaglutide (Wegovy) bit.ly/3UmgXaj Semaglutide (Wegovy) has been approved by the FDA to reduce the risk of major adverse cardiovascular events (MACE) in adults with established cardiovascular disease (CVD) and either obesity or overweight

This is a meaningful shift because it offers a non-injection option for patients who strongly prefer pills

MAC C-Thru Lipglass ($17.00 for 0.10 fl